Amid intense scrutiny of its prescribing practices, the online mental health company Cerebral launched a series of advertisements Thursday emphasizing affordable and easy screening and diagnosis of ADHD and a convenient way to get care.
The promotions, which appeared on a Meta advertising library and were viewed by STAT, were rolled out shortly after Cerebral announced it would pause the practice of prescribing controlled substances like Ritalin and Adderall to treat ADHD, effective May 9. The Drug Enforcement Administration has also reportedly launched an investigation into the licensing of the company’s providers and its handling of duplicate patient accounts, according to Business Insider. Cerebral would not confirm or comment on the investigation.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
